🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Wellbeing Nutrition claims Rs 170 Cr revenue in FY25; retail share at 25%

EntrackrEntrackr · 6m ago
Wellbeing Nutrition claims Rs 170 Cr revenue in FY25; retail share at 25%
Medial

Clean-label nutraceutical brand Wellbeing Nutrition closed FY25 with revenue of about Rs 170 crore, posting over 100% year-on-year growth. Losses, however, widened to a little over Rs 30 crore, according to the company’s spokesperson. In Q1 FY26, the Avnish Chhabria-led firm clocked around Rs 80 crore in revenue. At the contribution margin (CM3) level, losses were about 2%, which the company expects to improve in the coming quarters. For FY26, Wellbeing Nutrition is targeting gross sales of Rs 350 crore while narrowing its losses by 20–30%. It projects revenue of Rs 600–650 crore in FY27 and aims to turn EBITDA-profitable by the end of the current fiscal year, as per its press release. Online channels, including its D2C platform, Amazon, Nykaa, and quick commerce partners, contribute around 70% of sales. Retail through pharmacies, modern trade, malls, and airports makes up 25%, while exports account for 5–10%. The brand is present in more than 3,700 retail stores in India and ships to over 25 international markets, including the US, UK, UAE, and Southeast Asia. According to startup data platform TheKredible, Wellbeing Nutrition has raised close to $14 million to date, including a $10 million Series B round led by Fireside Ventures and Hindustan Unilever (HUL) in December 2022. Founded in 2019, the company has expanded its portfolio across categories such as sleep, immunity, beauty, and stress. It plans to roll out 20–25 new products in FY26 in emerging segments like kids’ nutrition and gut health. Wellbeing Nutrition competes with Oziva, Kapiva, Gynoveda, and Nyumi in India’s growing nutraceutical and wellness market. With consistent triple-digit growth and a focus on scale, the company is positioning itself among a handful of consumer health brands chasing profitability at a larger scale.

1

Related News

USV acquires 79% stake in Wellbeing Nutrition at Rs 1,583 Cr valuation

EntrackrEntrackr · 14d ago
USV acquires 79% stake in Wellbeing Nutrition at Rs 1,583 Cr valuation
Medial

USV acquires 79% stake in Wellbeing Nutrition at Rs 1,583 Cr valuation Pharmaceutical major USV has signed a definitive agreement to acquire a 79% stake in Nutritionalab Private Limited, the parent company of Wellbeing Nutrition, to enter India’s fast-growing direct-to-consumer nutraceutical and wellness market. The transaction values Wellbeing Nutrition at around Rs 1,583 crore. Founded in 2019, Wellbeing Nutrition operates in the nutraceutical segment with a product portfolio that includes vitamins, minerals, protein, collagen, omega supplements and other wellness products. The company sells through its own digital platform, online marketplaces and offline retail channels, and has a presence in international markets including the US, UK and UAE. Wellbeing Nutrition claimed revenue of around Rs 170 crore in FY25, with a loss of around Rs 30 crore. According to the company, it has recorded 120% growth over the past two years and is targeting revenue of over Rs 450 crore by FY27. According to startup data platform TheKredible, Wellbeing Nutrition has raised close to $14 million to date, including a $10 million Series B round led by Fireside Ventures and Hindustan Unilever (HUL) in December 2022. As part of the transaction, existing investors are set to exit partially or fully. HUL will sell its entire 19.8% stake to USV for about Rs 307 crore. HUL had invested around Rs 70 crore in Wellbeing Nutrition, and the exit translates into more than four times return on its original investment. Fireside Ventures and other early investors are also expected to dilute their holdings. USV has a six-decade presence in the Indian pharmaceutical market and is a leader in oral anti-diabetic and cardiovascular therapies, with brands such as Glycomet GP, Ecosprin and Roseday. The company is also the exclusive partner for Sebamed in India. With this acquisition, USV is expanding its portfolio beyond prescription medicines into preventive and lifestyle-focused wellness. This is the second major acquisition in India’s D2C space in 2026. Last week, Mumbai-based consumer goods major Marico acquired a 60% stake in plant-based protein startup Cosmix at an equity valuation of Rs 375 crore. The move comes amid a broader FMCG consolidation trend, following Hindustan Unilever Limited’s acquisition of skincare brand Minimalist last year at a pre-money valuation of Rs 2,955 crore.

D2C brand Wellness Nutrition raises debt

EntrackrEntrackr · 10m ago
D2C brand Wellness Nutrition raises debt
Medial

Wellbeing Nutrition, a D2C health & wellness startup, is raising Rs 25 crore (approximately $3 million) in debt funding led by pharma company ACG-Capsules with the participation of Maheshwari Investors Pvt Ltd, MGB Advisors, and Atmos Finance. The board at Wellbeing Nutrition passed a special resolution to issue 2,500 optionally convertible debentures (OCDs) at an issue price of Rs 1,00,000 each to raise Rs 25 crore or $3 million, its regulatory filing accessed from the Registrar of Companies (RoC) shows. ACG led the round with Rs 10 crore investment while Maheshwari Investors, MGB Advisors, and Atmos Finance will be contributing Rs 5 crore each. According to filings, the company will utilize these funds for general business operations, including capital and working capital expenditures. Founded by Avnish Chhabria, Wellbeing Nutrition is a whole-food nutrition company specializing in plant-based ingredients to promote overall wellness. Its product range includes solutions for daily wellness, sleep, headaches, gut health, hair loss, and skincare. According to startup data intelligence platform TheKredible, the D2C company has raised close to $14 million to date, including a $10 million Series B round raised from Fireside Ventures and Hindustan Unilever (HUL) in December 2022. For the fiscal year ended March 2024, Wellbeing Nutrition reported Rs 70 crore in operating revenue while incurring a loss of Rs 32 crore during the same period.

Spinny posts Rs 4,657 Cr revenue in FY25; cuts losses by 28%

EntrackrEntrackr · 5m ago
Spinny posts Rs 4,657 Cr revenue in FY25; cuts losses by 28%
Medial

Spinny posts Rs 4,657 Cr revenue in FY25; cuts losses by 28% Used car retailer Spinny posted a steady performance in FY25 with notable top-line growth and narrowing losses. The Gurugram-based company’s revenue from operations jumped 25% year-on-year to Rs 4,657 crore, up from Rs 3,730 crore in FY24, according to its consolidated financial statements filed with the Registrar of Companies (RoC). Spinny primarily generates its revenue from used car sales, accounting for 97.7% of its operating income (Rs 4,553 crore) from this segment, marking a 25.7% YoY rise during FY25. The balance came from commissions, support services, and advertising. Beyond operations, the company booked Rs 89 crore in non-operating income from interest on deposits, corporate bonds, mutual fund gains, and fair value adjustments. This pushed its total income to Rs 4,746 crore in FY25 from Rs 3,822 crore in FY24. For the used car retailer, the cost of procuring cars was naturally the largest cost center, accounting for 83.3% of the overall cost. In line with a 25% revenue surge, this cost grew 23% to Rs 4,309 crore in FY25. The firm cut its employee benefits by 13.8% to Rs 338 crore in the said year. Spinny’s direct cost stood at Rs 147 crore while its advertising and promotion costs reduced by 11.3% to Rs 125 crore in FY25. Other overheads, including information technology, legal, travelling, and rent, took the total cost to Rs 5,170 crore in FY25. The decent growth in its revenue helped Spinny to cut down its losses by 28.3% to Rs 423 crore in FY25 from Rs 590 crore in FY24. The company has also improved its per unit expense to revenue ratio in FY25, which was recorded at Rs 1.11. In March this year, the company closed $170 million round this year led by Accel Leaders Fund. According to startup data intelligence platform TheKredible, Spinny has raised around $676 million to date, including investors like Tiger Global, Accel, Elevation Capital, and others. The company expanded its portfolio by acquiring Autocar India, an auto media and car content platform, and started its own NBFC subsidiary.

Sid’s Farm posts Rs 168 Cr revenue in FY25; losses surge 2.6x

EntrackrEntrackr · 1m ago
Sid’s Farm posts Rs 168 Cr revenue in FY25; losses surge 2.6x
Medial

Sid’s Farm, a Hyderabad-based dairy brand, recorded a decent growth in revenue in the fiscal year ending March 2025. However, rising costs pushed the company deeper into losses. Sid’s Farm’s operating revenue increased by 38% to Rs 168 crore in FY25 from Rs 122 crore in FY24, according to its financial statements sourced from the Registrar of Companies (RoC). Founded in 2016, Sid’s Farm is a mass premium Hyderabad-based dairy brand. The startup controls the entire value chain of milk and milk products by sourcing directly from farmers. Including other income of Rs 2 crore, the company’s total income stood at Rs 170 crore in FY25. The surge in topline was accompanied by a faster rise in expenses. Sid’s Farm’s total expenses jumped 47% to Rs 196 crore in FY25 from Rs 133.5 crore in the previous fiscal year. Cost of material consumed remained the largest expense, accounting for over 64% of the overall costs. This expense rose 41% to Rs 126 crore in FY25. Employee benefit expenses increased by 47% to Rs 25 crore. Costs nearly doubled to Rs 7 crore in FY25 from Rs 3.6 crore in FY24. Distribution and transportation expenses grew to Rs 8 crore and Rs 5 crore, respectively. Other expenses added another Rs 25 crore during the year. The sharp increase in costs led Sid’s Farm’s losses to increase by 2.6x to Rs 27 crore in FY25 from Rs 10.5 crore in FY24. Its ROCE and EBITDA margin stood at -45.24% and -14.58% respectively. On a unit basis, Sid’s Farm spent Rs 1.17 to earn a rupee of operating revenue during the fiscal year, compared to Rs 1.09 in FY24. As of March 2025, the company’s cash and bank balances stood at Rs 1 crore, while current assets rose to Rs 45 crore in FY25. Sid’s Farms has raised approximately $12.2 million of funding to date, including the $10 million round co-led by Omnivore and Narotam Sekhsaria Family Office.

Smartworks clocks Rs 1,374 Cr revenue and Rs 62 Cr loss in FY25

EntrackrEntrackr · 7m ago
Smartworks clocks Rs 1,374 Cr revenue and Rs 62 Cr loss in FY25
Medial

Smartworks, a leading managed workspace platform, reported a 32% growth in operating revenue to Rs 1,374 crore in FY25. However, despite the strong topline growth, the company’s losses widened 26% in FY25. Smartworks’ revenue from operations increased by 32% to Rs 1374 crore in FY25 from Rs 1039 crore in FY24, according to its financial statement sourced from RHP. SmartWorks provides flexible office space for large enterprises, SMEs, and high-growth startups and leverages its robust phygital platform to deliver fully serviced, tech-enabled, flexible, and affordable workspaces. Lease rentals accounted for over 93% of its operating revenue, which rose by 29% to Rs 1,289 crore in FY25. Other sources included design and fit-out services at Rs 35 crore, ancillary services at Rs 49 crore, and a marginal Rs 1 crore from software fees. Smartworks added another Rs 36 crore from non-operating sources, which pushed its total revenue to Rs 1410 crore in FY25. On the expense side, the largest cost head was depreciation, which increased 35% to Rs 636 crore, followed by operating expenses of Rs 416 crore. Finance costs remained relatively stable at Rs 336 crore, while employee benefit expenses rose to Rs 65 crore. Overall, total expenses increased by 26% to Rs 1,489 crore in FY25 from Rs 1,180 crore in FY24. Despite revenue growth, the company’s loss increased by 26% to Rs 63 crore in FY25 as compared to Rs 50 crore in FY24. However, the company reported a positive EBITDA of Rs 893 crore in FY25 with an EBITDA margin of 63.3% and ROCE of 7.48%. On a unit level, Smartworks spent Rs 1.08 to earn a rupee of operating revenue in FY25, marginally better than the previous year’s ratio of Rs 1.14. The Gurugram-based company reported current assets worth Rs 255 crore in FY25, including Rs 69 crore in cash and bank balances. Smartworks is heading to the public markets with its Rs 583 crore IPO opening on July 10 and closing on July 14, 2025. The company has set a price band of Rs 387 to Rs 407 per share with a lot size of 36 shares, requiring a minimum investment of Rs 14,652 for retail investors.

Curefoods posts Rs 746 Cr revenue in FY25, dessert-led income grows 95%

EntrackrEntrackr · 8m ago
Curefoods posts Rs 746 Cr revenue in FY25, dessert-led income grows 95%
Medial

Curefoods posts Rs 746 Cr revenue in FY25, dessert-led income grows 95% Cloud kitchen brand Curefoods has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for an Initial Public Offering (IPO). The move follows the company’s FY25 financial performance, where it reported a revenue of Rs 746 crore and a loss of Rs 170 crore, according to its balance sheet. Curefoods' operating revenue increased by 28% to Rs 746 crore in FY25 from Rs 585 crore in FY24, while its losses remained flat in the last fiscal year. Curefoods operates a multi-brand cloud kitchen business across categories like Indian meals, pizza, desserts, and health-focused food. In FY25, desserts led revenue with Rs 196 crore, followed by pizza (Rs 183 crore), Indian meals (Rs 178 crore), and healthy meals (Rs 176 crore). While desserts and pizza grew 18% and 95% YoY, respectively, the healthy segment declined by 13%. The Bengaluru-based company added Rs 29 crore from interest on financial assets which pushed its total income to Rs 775 crore in FY25. On the expense side, the cost of materials accounted for the largest share at Rs 273 crore, followed by employee benefit expenses at Rs 180 crore and commissions at Rs 137 crore. Advertising costs jumped significantly by over 64% to Rs 87 crore. Overall, the company’s total expenditure stood at Rs 944 crore in FY25, rising by 17% from Rs 807 crore in FY24. Despite the revenue growth, Curefoods’ loss remained flat at Rs 170 crore in FY25 from Rs 173 crore in FY24. Its ROCE and EBITDA margin stood at -19% and -7.5%, respectively. On a unit level, the company spent Rs 1.27 to earn a rupee of operating revenue in FY25. As of March 2025, the Ankit Nagori-led company had current assets worth Rs 339 crore in FY25, including Rs 80 crore in cash and bank balances. Curefoods’ founder Nagori is entitled to an annual fixed remuneration of Rs 3 crore (inclusive of perquisites and retirement benefits) and an annual variable bonus of up to 20% of his remuneration. Curefoods’ operational performance improved in FY25, with average daily sales rising to Rs 2 crore from Rs 1.5 crore in FY24, amid strong consumer demand across its brands. Among its 10 key brands, Sharief Bhai, EatFit, and CakeZone led revenue with Rs 148 crore, Rs 145 crore, and Rs 102 crore, respectively. The company also added new revenue streams through the launch of Krispy Kreme operations in South, West, and North India, with Rs 15 crore in revenue in FY25 after acquiring the franchise rights. The improving numbers certainly indicate a level of maturity for the business, prompting the move to go public as well. However, risks remain, particularly in the performance of the ‘Healthy Foods’ segment and now, the Krispy Kreme franchise, which has not quite delivered in India, and continues to face a tough challenge to crack the local market. Curefoods and its multi-brand approach remains to be tested, especially with profits still distant, and H1 of FY26 will probably be a good time to evaluate if the firm has discovered a path to profitability.

Kapiva spends Rs 188 Cr on advertising in FY25; posts Rs 342 Cr revenue

EntrackrEntrackr · 1m ago
Kapiva spends Rs 188 Cr on advertising in FY25; posts Rs 342 Cr revenue
Medial

Kapiva sustained its strong growth momentum in the fiscal year ended March 31, 2025, as revenue rose nearly 50% year on year. However, higher incremental spending during the year weighed on the bottom line and led to a 23% increase in the company’s losses over the same period. Kapiva’s revenue from operations grew 50% to Rs 342 crore in FY25 from Rs 228 crore in FY24, according to its consolidated financial statements sourced from the Registrar of Companies (RoC). Founded in 2015, Kapiva is an ayurvedic nutrition brand offering natural and organic products in categories such as diabetes, hypertension, liver health, hormonal balance, wellness, energy, and sports nutrition. Sale of these products was the sole source of revenue for the company. Including non-operating income of Rs 7 crore, the company’s total income stood at Rs 349 crore in FY25. For the D2C brand, advertising and promotional expenditure remained the largest cost contributor, accounting for 45% of the total expense. This cost rose 53% to Rs 188 crore in FY25 from Rs 123 crore in FY24. Cost of materials consumed grew 43% to Rs 97 crore, contributing about 23% of overall costs, while employee benefit expenses increased 28% to Rs 59 crore. Transportation cost stood at Rs 22 crore, legal charges doubled to Rs 16 crore, and other overheads added another Rs 36 crore during the year. Overall, the company’s total expense rose 44% to Rs 418 crore in FY25 from Rs 290 crore in FY24. Kapiva’s net loss rose 23% to Rs 69 crore in FY25 from Rs 56 crore in FY24. Its ROCE and EBITDA margin stood at -51.41% and -20.88% respectively. On a unit level, the company spent Rs 1.22 to earn a rupee, better than Rs 1.27 it spent in FY24. The company recorded cash and bank balances of Rs 139 crore, while its current assets were valued at Rs 199 crore in the same period.

Hindustan Unilever acquires remaining 49% stake in OZiva for Rs 824 Cr

EntrackrEntrackr · 12d ago
Hindustan Unilever acquires remaining 49% stake in OZiva for Rs 824 Cr
Medial

Hindustan Unilever acquires remaining 49% stake in OZiva for Rs 824 Cr Mumbai-based FMCG major Hindustan Unilever Limited has completed the acquisition of the remaining 49% stake in OZiva, operated through Zywie Ventures Private Limited, for a total consideration of Rs 824 crore. The transaction makes OZiva a wholly owned subsidiary of HUL. The deal shows a sharp jump in OZiva’s valuation. In December 2022, HUL had acquired a 51% stake in OZiva for a cash consideration of Rs 264.28 crore, which implied a valuation of around Rs 518 crore at the time. The latest transaction values the company at nearly Rs 1,682 crore and represents a more than threefold increase over a little more than three years. Founded in 2019, the six-year-old direct-to-consumer firm sells plant-based nutrition products across health, skin, hair, and general wellness categories. Prior to the HUL transaction, OZiva had raised around $17 million from investors such as Matrix Partners, Eight Road Ventures, and Stride Ventures. The company also reported a sharp improvement in operating performance. Its revenue from operations jumped 148% to Rs 258 crore in FY25 from Rs 104 crore in FY24 while losses declined 90% to Rs 4.5 crore in FY25 compared to Rs 43.5 crore in the previous fiscal. The deal follows a series of acquisitions in India’s D2C space this year. On Thursday, pharmaceutical major USV acquired a 79% stake in Wellbeing Nutrition. Earlier this month, Mumbai-based consumer goods major Marico acquired a 60% stake in plant-based protein startup Cosmix at an equity valuation of Rs 375 crore. The trend builds on last year’s consolidation, which included HUL’s acquisition of skincare brand Minimalist at a pre-money valuation of Rs 2,955 crore.

Healthkart’s revenue nears Rs 1,400 Cr in FY25; profit triples

EntrackrEntrackr · 3m ago
Healthkart’s revenue nears Rs 1,400 Cr in FY25; profit triples
Medial

Healthkart’s revenue nears Rs 1,400 Cr in FY25; profit triples HealthKart, a nutrition and supplement e-commerce platform, recorded a 3X year-on-year jump in profit after turning profitable in FY24. The Gurugram-based company’s sharp profit growth was steered by strong sales momentum and a controlled cost structure. Healthkart’s operating revenue grew 29% to Rs 1,313 crore in FY25 from Rs 1,021 crore in FY24, according to its consolidated financial statement sourced from the Registrar of Companies (RoC). HealthKart owns and manufactures eight nutritional brands including popular supplement brands like MuscleBlaze, The Protein Zone, TrueBasics, HKVitals, bGreen, Nouriza, and Gritzo. Sales of products formed 97% of total revenue which rose by 29% to Rs 1,277 crore in FY25. Collections from services also increased by 16% to Rs 36 crore. Notably, non-operating revenue increased to Rs 55 crore in the last fiscal year from Rs 48 crore in FY24. The cost of materials accounted for the largest share of the company’s expenditure at 49%. To the tune of scale, this cost rose 26% to Rs 623 crore in FY25 from Rs 495 crore in FY25. Advertising spend saw a sharper rise of 39% to Rs 263 crore, while commission expenses increased 22% to Rs 82 crore. In contrast, employee benefit costs declined 5% to Rs 115 crore. Overall, Healthkart managed to keep its cost growth below revenue expansion. Its total expenses rose 23% to Rs 1,273 crore in FY25 from Rs 1,032 crore in FY24. The company’s profit surged over 3X to Rs 120 crore in FY25, while its ROCE and EBITDA margin improved to 5.45% and 6.02%, respectively. On a unit basis, Healthkart spent Re 0.97 to earn a rupee of operating revenue in FY25, compared to Rs 1.01 in FY24. As of FY25, its current assets stood at Rs 971 crore including Rs 73 crore in cash and bank balances. According to startup data intelligence platform TheKredible, Healthkart has raised a total of $382 million of funding till date, having Peak XV Partners, Temasek and Sofina as its lead investors. The company’s founder and CEO, Sameer Maheshwari owns 12% of the company.

Download the medial app to read full posts, comements and news.